A Study of Radiation Therapy Before CAR T Cell Therapy for People With B Cell Lymphoma

NCT05574114 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin Lymphoma
Non-Hodgkin's Lymphoma, Relapsed
Non-Hodgkin's Lymphoma Refractory

Interventions

RADIATION: Bridging radiotherapy (BRT)
DRUG: Conditioning chemotherapy
BIOLOGICAL: CAR T-cell product

Sponsor

Memorial Sloan Kettering Cancer Center